Unbound MEDLINE

Sumatriptan inhibition of N-type calcium channel mediated signaling in dural CGRP terminal fibres.

Abstract

The selective 5-HT₁ receptor agonist sumatriptan is an effective therapeutic for migraine pain yet the antimigraine mechanisms of action remain controversial. Pain-responsive fibres containing calcitonin gene-related peptide (CGRP) densely innervating the cranial dura mater are widely believed to be an essential anatomical substrate for the development of migraine pain. 5-HT₁ receptors in the dura colocalize with CGRP fibres in high density and thus provide a possible peripheral site of action for sumatriptan. In the present study, we used high-resolution optical imaging selectively within individual mouse dural CGRP nociceptive fibre terminations and found that application of sumatriptan caused a rapid, reversible dose-dependent inhibition in the amplitude of single action potential evoked Ca²⁺ transients. Pre-application of the 5-HT₁ antagonist GR 127935 or the selective 5-HT(1D) antagonist BRL 15572 prevented inhibition while the selective 5-HT(1B) antagonist SB 224289 did not, suggesting this effect was mediated selectively through the 5-HT(1D) receptor subtype. Sumatriptan inhibition of the action potential evoked Ca²⁺ signaling was mediated selectively through N-type Ca²⁺ channels. Although the T-type Ca²⁺ channel accounted for a greater proportion of the Ca²⁺ signal it did not mediate any of the sumatriptan inhibition. Our findings support a peripheral site of action for sumatriptan in inhibiting the activity of dural pain fibres selectively through a single Ca²⁺ channel subtype. This finding adds to our understanding of the mechanisms that underlie the clinical effectiveness of 5-HT₁ receptor agonists such as sumatriptan and may provide insight for the development of novel peripherally targeted therapeutics for mitigating the pain of migraine.

Links

  • Publisher Full Text
  • Authors

    Baillie LD, Ahn AH, Mulligan SJ

    Institution

    Department of Physiology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. ldb874@mail.usask.ca

    Source

    Neuropharmacology 63:3 2012 Sep pg 362-7

    MeSH

    Action Potentials
    Animals
    Calcitonin Gene-Related Peptide
    Calcium Channel Blockers
    Calcium Channels, N-Type
    Calcium Signaling
    Dura Mater
    Electric Stimulation
    Immunohistochemistry
    Mice
    Mice, Transgenic
    Microscopy, Fluorescence
    Nerve Fibers
    Pain
    Presynaptic Terminals
    Serotonin 5-HT1 Receptor Agonists
    Serotonin 5-HT1 Receptor Antagonists
    Serotonin Receptor Agonists
    Sumatriptan

    Pub Type(s)

    Journal Article
    Research Support, N.I.H., Extramural
    Research Support, Non-U.S. Gov't

    Language

    eng

    PubMed ID

    22691374